Departement
Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Zurück
Publications Liechti Matthias Emanuel

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.

Holze F; Vizeli P; Ley L; Müller F; Dolder P; Stocker M; Duthaler U; Varghese N; Eckert A; Borgwardt S; Liechti ME. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2021.

Acute subjective effects in LSD- and MDMA-assisted psychotherapy.

Schmid Y; Gasser P; Oehen P; Liechti ME. Journal of psychopharmacology (Oxford, England). 2021.

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.

Ramaekers JG; Hutten N; Mason NL; Dolder P; Theunissen EL; Holze F; Liechti ME; Feilding A; Kuypers KP. Journal of psychopharmacology (Oxford, England). 2021.

Correction to: Safety pharmacology of acute LSD administration in healthy subjects (Psychopharmacology, (2021), 10.1007/s00213-021-05978-6)

Holze F.; Caluori T.V.; Vizeli P.; Liechti M.E.. Psychopharmacology. 2021.

Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin's main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma

Kolaczynska K.E.; Liechti M.E.; Duthaler U.. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2021.

Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases

Dolder P.C.; Liechti M.E.; Rentsch K.M.. Analytical and bioanalytical chemistry. 2021.

Drugs of Abuse Affecting 5-HT2B Receptors

Luethi D.; Liechti M.E.. . 2021.

Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis.

Vizeli P; Straumann I; Holze F; Schmid Y; Dolder PC; Liechti ME. Scientific Reports. 2021.

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers

Hutten N.R.P.W.; Mason N.L.; Dolder P.C.; Theunissen E.L.; Holze F.; Liechti M.E.; Varghese N.; Eckert A.; Feilding A.; Ramaekers J.G.; Kuypers K.P.C.. ACS Pharmacology and Translational Science. 2021.

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens.

Müller F; Holze F; Dolder P; Ley L; Vizeli P; Soltermann A; Liechti ME; Borgwardt S. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2021.

MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014-2017.

Noseda R; Schmid Y; Scholz I; Liakoni E; Liechti ME; Dargan PI; Wood DM; Dines AM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; Ceschi A; Euro-DEN Research Group.. Clinical toxicology (Philadelphia, Pa.). 2021.

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.

Holze F; Liechti ME; Hutten NRPW; Mason NL; Dolder PC; Theunissen EL; Duthaler U; Feilding A; Ramaekers JG; Kuypers KPC. Clinical pharmacology and therapeutics. 2021.

Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies

Studerus E.; Vizeli P.; Harder S.; Ley L.; Liechti M.E.. Journal of psychopharmacology (Oxford, England). 2021.

Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin

Holze F.; Avedisian I.; Varghese N.; Eckert A.; Liechti M.E.. Frontiers in Pharmacology. 2021.

Safety pharmacology of acute LSD administration in healthy subjects

Holze F.; Caluori T.V.; Vizeli P.; Liechti M.E.. Psychopharmacology. 2021.

The pharmacological profile of second generation pyrovalerone cathinones and related cathinone derivative

Kolaczynska K.E.; Thomann J.; Hoener M.C.; Liechti M.E.. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021.

Variation of drugs involved in acute drug toxicity presentations based on age and sex: an epidemiological approach based on European emergency departments

Miro O.; Waring W.S.; Dargan P.I.; Wood D.M.; Dines A.M.; Yates C.; Giraudon I.; Moughty A.; O'Connor N.; Heyerdahl F.; Hovda K.E.; Vallersnes O.M.; Paasma R.; Pold K.; Jurgens G.; Megarbane B.; Anand J.S.; Liakoni E.; Liechti M.; Eyer F.; Zacharov S.; Caganova B.; Bonnici J.; Radenkova-Saeva J.; Galicia M.. Clinical toxicology (Philadelphia, Pa.). 2021.

<i>Para</i>-Halogenation of Amphetamine and Methcathinone Increases the Mitochondrial Toxicity in Undifferentiated and Differentiated SH-SY5Y Cells.

Zhou X; Bouitbir J; Liechti ME; Krähenbühl S; Mancuso RV. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020.

Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of <i>In Vitro</i> Methods to Assess the Potency of Drugs That Target Monoamine Transporters.

Ilic M; Holy M; Jaentsch K; Liechti ME; Lubec G; Baumann MH; Sitte HH; Luethi D. Frontiers in Pharmacology. 2020.

Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication.

Grafinger KE; Liechti ME; Liakoni E. British journal of clinical pharmacology. 2020.

Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans.

Steuer AE; Kaelin D; Boxler MI; Eisenbeiss L; Holze F; Vizeli P; Czerwinska J; Dargan PI; Abbate V; Liechti ME; Kraemer T. Metabolites. 2020.

Designer drugs: mechanism of action and adverse effects.

Luethi D; Liechti ME. ARCHIVES OF TOXICOLOGY. 2020.

Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.

Holze F; Vizeli P; Müller F; Ley L; Duerig R; Varghese N; Eckert A; Borgwardt S; Liechti ME. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2020.

Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland.

Schmid Y; Scholz I; Mueller L; Exadaktylos AK; Ceschi A; Liechti ME; Liakoni E. Drug and alcohol dependence. 2020.

Hyperthermia Increases Neurotoxicity Associated with Novel Methcathinones.

Zhou X; Bouitbir J; Liechti ME; Krähenbühl S; Mancuso RV. Cells. 2020.

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.

Hutten NRPW; Mason NL; Dolder PC; Theunissen EL; Holze F; Liechti ME; Feilding A; Ramaekers JG; Kuypers KPC. European Neuropsychopharmacology. 2020.

The neurobehavioral effects of the designer drug naphyrone - an experimental investigation with pharmacokinetics and concentration/effect relationship in mice.

Mégarbane B; Gamblin C; Roussel O; Bouaziz-Amar E; Chevillard L; Callebert J; Chen H; Morineau G; Laplanche JL; Etheve-Quelquejeu M; Liechti ME; Benturquia N. Psychopharmacology. 2020.

Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects

Muller F.; Muhlhauser M.; Holze F.; Lang U.E.; Walter M.; Liechti M.E.; Borgwardt S.. Frontiers in Psychiatry. 2020.

[Knockout Drugs: Diagnostics in the Emergency Unit and Clinical Practice].

Bühler T; Schmid Y; Liechti ME. Praxis. 2019.

<i>Para</i>-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones.

Luethi D; Walter M; Zhou X; Rudin D; Krähenbühl S; Liechti ME. Frontiers in Pharmacology. 2019.

Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use.

Luethi D; Hoener MC; Krähenbühl S; Liechti ME; Duthaler U. Biochemical pharmacology. 2019.

Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study.

Strajhar P; Vizeli P; Patt M; Dolder PC; Kratschmar DV; Liechti ME; Odermatt A. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. 2019.

Emergency department presentations related to abuse of prescription and over-the-counter drugs in Switzerland: time trends, sex and age distribution.

Scholz I; Schmid Y; Exadaktylos AK; Haschke M; Liechti ME; Liakoni E. Swiss medical weekly. 2019.

Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems.

Luethi D; Kolaczynska KE; Walter M; Suzuki M; Rice KC; Blough BE; Hoener MC; Baumann MH; Liechti ME. Journal of psychopharmacology (Oxford, England). 2019.

Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts.

Zhou X; Luethi D; Sanvee GM; Bouitbir J; Liechti ME; Krähenbühl S. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2019.

Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives).

Luethi D; Widmer R; Trachsel D; Hoener MC; Liechti ME. European journal of pharmacology. 2019.

Neuroimaging of chronic MDMA ("ecstasy") effects: A meta-analysis.

Müller F; Brändle R; Liechti ME; Borgwardt S. Neuroscience and biobehavioral reviews. 2019.

No Influence of Dopamine System Gene Variations on Acute Effects of MDMA.

Vizeli P; Liechti ME. Frontiers in Psychiatry. 2019.

Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects.

Holze F; Duthaler U; Vizeli P; Müller F; Borgwardt S; Liechti ME. British journal of clinical pharmacology. 2019.

Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions.

Leuppi-Taegtmeyer A; Duthaler U; Hammann F; Schmid Y; Dickenmann M; Amico P; Jehle AW; Kalbermatter S; Lenherr C; Meyer Zu Schwabedissen HE; Haschke M; Liechti ME; Krähenbühl S. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2019.

Pharmacological characterization of the aminorex analogs 4-MAR, 4,4'-DMAR, and 3,4-DMAR.

Rickli A; Kolaczynska K; Hoener MC; Liechti ME. Neurotoxicology. 2019.

Pharmacological profiles of compounds in preworkout supplements ("boosters").

Rickli A; Hoener MC; Liechti ME. European journal of pharmacology. 2019.

Poor Identification of Emergency Department Acute Recreational Drug Toxicity Presentations Using Routine Hospital Coding Systems: the Experience in Denmark, Switzerland and the UK.

Wood DM; De La Rue L; Hosin AA; Jurgens G; Liakoni E; Heyerdahl F; Hovda KE; Dines A; Giraudon I; Liechti ME; Dargan PI. Journal of Medical Toxicology. 2019.

Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines.

Kolaczynska KE; Luethi D; Trachsel D; Hoener MC; Liechti ME. Frontiers in Pharmacology. 2019.

Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects.

Vizeli P; Meyer Zu Schwabedissen HE; Liechti ME. ACS Chemical Neuroscience. 2019.

Stereochemistry of phase-1 metabolites of mephedrone determines their effectiveness as releasers at the serotonin transporter.

Mayer FP; Cintulova D; Pittrich DA; Wimmer L; Luethi D; Holy M; Jaentsch K; Tischberger S; Gmeiner G; Hoener MC; Liechti ME; Mihovilovic MD; Sitte HH. NEUROPHARMACOLOGY. 2019.

Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects.

Dolder PC; Strajhar P; Vizeli P; Odermatt A; Liechti ME. Psychopharmacology. 2018.

Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing.

Schmidt A; Müller F; Dolder PC; Schmid Y; Zanchi D; Egloff L; Liechti ME; Borgwardt S. International Journal of Neuropsychopharmacology. 2018.

Acute LSD effects on response inhibition neural networks

Schmidt A.; Muller F.; Lenz C.; Dolder P.C.; Schmid Y.; Zanchi D.; Lang U.E.; Liechti M.E.; Borgwardt S.. Psychological medicine. 2018.

Acute recreational drug toxicity: Comparison of self-reports and results of immunoassay and additional analytical methods in a multicenter European case series.

Liakoni E; Yates C; Dines AM; Dargan PI; Heyerdahl F; Hovda KE; Wood DM; Eyer F; Liechti ME; Euro-DEN Plus Research Group.. Medicine. 2018.

Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.

Müller F; Liechti ME; Lang UE; Borgwardt S. Progress in Brain Research. 2018.

Altered network hub connectivity after acute LSD administration

Muller F.; Dolder P.C.; Schmidt A.; Liechti M.E.; Borgwardt S.. NeuroImage-Clinical. 2018.

Chiral analysis of amphetamines in hair by liquid chromatography-tandem mass spectrometry: compliance-monitoring of attention deficit hyperactivity disorder (ADHD) patients under Elvanse® therapy and identification after controlled low-dose application.

Binz TM; Williner E; Strajhar P; Dolder PC; Liechti ME; Baumgartner MR; Kraemer T; Steuer AE. Drug testing and analysis. 2018.

Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.

Dolder PC; Liechti ME; Rentsch KM. JOURNAL OF CLINICAL LABORATORY ANALYSIS. 2018.

Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects.

Dolder PC; Müller F; Schmid Y; Borgwardt SJ; Liechti ME. Psychopharmacology. 2018.

Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems.

Luethi D; Hoener MC; Liechti ME. European journal of pharmacology. 2018.

Emergencies related to recreational drug abuse in Spain compared to emergencies attended in 3 European areas.

Miró Ò; Yates C; Dines AM; Wood DM; Dargan PI; Galán I; Jerez A; Puiguriguer J; Waring WS; Moughty A; O'Connor N; Heyerdahl F; Hovda KE; Vallersnes OM; Paasma R; Põld K; Jürgens G; Megarbane B; Anand JS; Liakoni E; Liechti M; Eyer F; Zacharov S; Caganova B; Giraudon I; Galicia M. Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias. 2018.

Human Metabolome Changes after a Single Dose of 3,4-Methylenedioxymethamphetamine (MDMA) with Special Focus on Steroid Metabolism and Inflammation Processes.

Boxler MI; Streun GL; Liechti ME; Schmid Y; Kraemer T; Steuer AE. JOURNAL OF PROTEOME RESEARCH. 2018.

Long-lasting subjective effects of LSD in normal subjects.

Schmid Y; Liechti ME. Psychopharmacology. 2018.

Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs).

Luethi D; Trachsel D; Hoener MC; Liechti ME. NEUROPHARMACOLOGY. 2018.

Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics.

Luethi D; Liechti ME. International Journal of Neuropsychopharmacology. 2018.

No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA.

Vizeli P; Meyer Zu Schwabedissen HE; Liechti ME. European journal of clinical pharmacology. 2018.

Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome.

Rickli A; Liakoni E; Hoener MC; Liechti ME. British Journal of Pharmacology. 2018.

Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects.

Vizeli P; Liechti ME. PLoS One. 2018.

Pharmacological profile of mephedrone analogs and related new psychoactive substances.

Luethi D; Kolaczynska KE; Docci L; Krähenbühl S; Hoener MC; Liechti ME. NEUROPHARMACOLOGY. 2018.

Pharmacological profile of methylphenidate-based designer drugs.

Luethi D; Kaeser PJ; Brandt SD; Krähenbühl S; Hoener MC; Liechti ME. NEUROPHARMACOLOGY. 2018.

Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.

Simmler LD; Liechti ME. Handbook of experimental pharmacology. 2018.

The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters.

Maier J; Mayer FP; Luethi D; Holy M; Jäntsch K; Reither H; Hirtler L; Hoener MC; Liechti ME; Pifl C; Brandt SD; Sitte HH. NEUROPHARMACOLOGY. 2018.

Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects

Mueller F.; Lenz C.; Dolder P.C.; Harder S.; Schmid Y.; Lang U.E.; Liechti M.E.; Borgwardt S.. Translational Psychiatry. 2017.

Alcohol acutely enhances decoding of positive emotions and emotional concern for positive stimuli and facilitates the viewing of sexual images

Dolder P.C.; Holze F.; Liakoni E.; Harder S.; Schmid Y.; Liechti M.E.. Psychopharmacology. 2017.

Alterations of consciousness and mystical-type experiences after acute LSD in humans.

Liechti ME; Dolder PC; Schmid Y. Psychopharmacology. 2017.

A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (<i>HTR2A</i>) or Early Growth Response Genes (<i>EGR1-3</i>) in Healthy Subjects.

Dolder PC; Grünblatt E; Müller F; Borgwardt SJ; Liechti ME. Frontiers in Pharmacology. 2017.

Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects.

Schmidt A; Müller F; Dolder PC; Schmid Y; Zanchi D; Liechti ME; Borgwardt S. International Journal of Neuropsychopharmacology. 2017.

Comparison of self-reported recreational substance use with immunoassay and liquid chromatography mass spectrometry findings in cases with acute recreational drug toxicity

Liakoni, Evangelia; Dolder, Patrick C.; Rentsch, Katharina M.; Liechti, Matthias E.. Clinical toxicology (Philadelphia, Pa.). 2017.

Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans.

Steuer AE; Poetzsch M; Stock L; Eisenbeiss L; Schmid Y; Liechti ME; Kraemer T. Drug testing and analysis. 2017.

First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects.

Boxler MI; Liechti ME; Schmid Y; Kraemer T; Steuer AE. JOURNAL OF PROTEOME RESEARCH. 2017.

Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations

Muller F.; Lenz C.; Dolder P.; Lang U.; Schmidt A.; Liechti M.; Borgwardt S.. ACTA PSYCHIATRICA SCANDINAVICA. 2017.

Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells.

Simmler LD; Liechti ME. Current topics in behavioral neurosciences. 2017.

Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.

Miró Ò; Galicia M; Dargan P; Dines AM; Giraudon I; Heyerdahl F; Hovda KE; Yates C; Wood DM; Liakoni E; Liechti M; Jürgens G; Pedersen CB; O'Connor N; Markey G; Moughty A; Lee C; O'Donohoe P; Sein Anand J; Puiguriguer J; Homar C; Eyer F; Vallersnes OM; Persett PS; Chevillard L; Mégarbane B; Paasma R; Waring WS; Põld K; Rabe C; Kabata PM. TOXICOLOGY LETTERS. 2017.

Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones.

Luethi D; Liechti ME; Krähenbühl S. Toxicology. 2017.

Mistaking 2C-P for 2C-B: What a Difference a Letter Makes.

Stoller A; Dolder PC; Bodmer M; Hammann F; Rentsch KM; Exadaktylos AK; Liechti ME; Liakoni E. JOURNAL OF ANALYTICAL TOXICOLOGY. 2017.

Modern Clinical Research on LSD.

Liechti ME. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2017.

Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies.

Kuypers KPC; Dolder PC; Ramaekers JG; Liechti ME. Journal of psychopharmacology (Oxford, England). 2017.

Pharmacogenetics of 3,4-methylenedioxymethamphetamine (MDMA): cytochrome P450 polymorphisms moderate pharmacokinetics and pharmacodynamic effects of MDMA in healthy subjects

Vizeli, Patrick; Schmid, Yasmin; Liechti, Matthias E.. Clinical toxicology (Philadelphia, Pa.). 2017.

Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects.

Vizeli P; Schmid Y; Prestin K; Meyer Zu Schwabedissen HE; Liechti ME. European Neuropsychopharmacology. 2017.

Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects.

Dolder PC; Strajhar P; Vizeli P; Hammann F; Odermatt A; Liechti ME. Frontiers in Pharmacology. 2017.

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.

Dolder PC; Schmid Y; Steuer AE; Kraemer T; Rentsch KM; Hammann F; Liechti ME. Clinical pharmacokinetics. 2017.

Pharmacokinetics and pharmacodynamics of two doses of oral LSD in healthy subjects

Liechti, Matthias E.; Schmid, Yasmin; Rentsch, Katharina M.; Hammann, Felix; Dolder, Patrick C.. Clinical toxicology (Philadelphia, Pa.). 2017.

Presentations to an urban emergency department in Bern, Switzerland associated with acute recreational drug toxicity.

Liakoni E; Müller S; Stoller A; Ricklin M; Liechti ME; Exadaktylos AK. Scandinavian Journal of Trauma Resuscitation & Emergency Medicine. 2017.

Pre-workout supplements: an analysis of their chemical content and pharmacodynamic interactions with monoamine transporters

Rickli, Anna; Liechti, Matthias E.. Clinical toxicology (Philadelphia, Pa.). 2017.

Safety pharmacology of acute MDMA administration in healthy subjects.

Vizeli P; Liechti ME. Journal of psychopharmacology (Oxford, England). 2017.

The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation.

Preller KH; Herdener M; Pokorny T; Planzer A; Kraehenmann R; Stämpfli P; Liechti ME; Seifritz E; Vollenweider FX. Current biology : CB. 2017.

Acute dose-response effects of LSD in healthy humans

Dolder, P. C.; Schmid, Y.; Mueller, F.; Borgwardt, S.; Rentsch, K. M.; Liechti, M. E.. European Neuropsychopharmacology. 2016.

Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects

Strajhar P.; Schmid Y.; Liakoni E.; Dolder P.C.; Rentsch K.M.; Kratschmar D.V.; Odermatt A.; Liechti M.E.. Journal of Neuroendocrinology. 2016.

Acute emotional and social cognitive effects of beer

Dolder, P.; Holze, F.; Harder, S.; Liechti, M.. European Neuropsychopharmacology. 2016.

Cytochrome 2D6 function moderates the pharmacokinetics and pharmacodynamics of MDMA in healthy subjects

Schmid, Y.; Vizeli, P.; Hysek, C.; Prestin, K.; zu Schwabedissen, H. Meyer; Liechti, M.. European Neuropsychopharmacology. 2016.

Delirium following loperamide overdose: a case report

Hammann, Felix; Liechti, Matthias E.. Clinical toxicology (Philadelphia, Pa.). 2016.

Development of a high-speed MALDI-triple quadrupole mass spectrometric method for the determination of 3,4-methylenedioxymethamphetamine (MDMA) in oral fluid.

Poetzsch M; Steuer AE; Hysek CM; Liechti ME; Kraemer T. Drug testing and analysis. 2016.

Effects of opioids at monoamine transporters: a potential for interactions of pain medications with antidepressants

Rickli, A.; Liechti, M. E.. European Neuropsychopharmacology. 2016.

Evaluation of drug incorporation into hair segments and nails by enantiomeric analysis following controlled single MDMA intakes.

Madry MM; Steuer AE; Hysek CM; Liechti ME; Baumgartner MR; Kraemer T. Analytical and bioanalytical chemistry. 2016.

Hepatotoxicity of novel psychoactive substances structurally related to 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine

Luethi, Dino; Krahenbuhl, Stephan; Liechti, Matthias E.. Clinical toxicology (Philadelphia, Pa.). 2016.

Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans.

Steuer AE; Schmidhauser C; Tingelhoff EH; Schmid Y; Rickli A; Kraemer T; Liechti ME. PLoS One. 2016.

In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1.

Simmler LD; Buchy D; Chaboz S; Hoener MC; Liechti ME. Journal of Pharmacology and Experimental Therapeutics. 2016.

In vitro pharmacological profiles of classic psychedelics and novel synthetic hallucinogenic substances and their relevance for clinical toxicology

Rickli, Anna; Luethi, Dino; Hoener, Marius C.; Liechti, Matthias E.. Clinical toxicology (Philadelphia, Pa.). 2016.

LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality.

Dolder PC; Schmid Y; Müller F; Borgwardt S; Liechti ME. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2016.

Monoamine transporter and receptor interaction profiles of novel phenethylamine derivatives

Luethi, D.; Kaeser, P. J.; Rickli, A.; Hoener, M. C.; Liechti, M. E.. European Neuropsychopharmacology. 2016.

Neuroimaging in moderate MDMA use: A systematic review

Mueller F.; Lenz C.; Steiner M.; Dolder P.C.; Walter M.; Lang U.E.; Liechti M.E.; Borgwardt S.. Neuroscience and biobehavioral reviews. 2016.

Pharmacokinetics and concentration-effect relationship of oral LSD in humans

Dolder P.C.; Schmid Y.; Haschke M.; Rentsch K.M.; Liechti M.E.. International Journal of Neuropsychopharmacology. 2016.

Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.

Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG. British journal of clinical pharmacology. 2016.

Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.

Liakoni E; Dolder PC; Rentsch KM; Liechti ME. BMC pharmacology &amp; toxicology. 2016.

Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.

Liakoni E; Walther F; Nickel CH; Liechti ME. Scandinavian Journal of Trauma Resuscitation & Emergency Medicine. 2016.

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.

Rickli A; Moning OD; Hoener MC; Liechti ME. European Neuropsychopharmacology. 2016.

Similar and Different? Subjective Effects of Methylphenidate and Cocaine in Opioid-Maintained Patients.

Vogel M; Bucher P; Strasser J; Liechti ME; Krähenbühl S; Dürsteler KM. Journal of psychoactive drugs. 2016.

Torsades de pointes due to co-administration of methadone and moxifloxacin

Liakoni, Evangelia; Huber, Xaver; Stegert, Mihaela; Crettol, Steverine; Eap, Chin B.; Liechti, Matthias E.. Clinical toxicology (Philadelphia, Pa.). 2016.

Variability of neurobehavioral toxicity of naphyrone, a new synthetic cathinone, with acute or binge administration

Benturquia, Nadia; Gamblin, Camille; Chevillard, Lucie; Roussel, Olivier; Risede, Patricia; Callebert, Jacques; Liechti, Matthias E.; Megarbane, Bruno. Clinical toxicology (Philadelphia, Pa.). 2016.

[In Process Citation].

Filippi C; Filippi A; Verna C. Swiss dental journal. 2015.

[Not Available].

Liakoni, Evangelia; Liechti, Matthias E. Swiss dental journal. 2015.

Acute autonomic and psychotropic effects of LSD in healthy subjects in a placebo-controlled study

Schmid, Yasmin; Dolder, Patrick C.; Liechti, Matthias E.. Clinical toxicology (Philadelphia, Pa.). 2015.

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects.

Schmid Y; Enzler F; Gasser P; Grouzmann E; Preller KH; Vollenweider FX; Brenneisen R; Müller F; Borgwardt S; Liechti ME. Biological psychiatry. 2015.

Acute health problems due to recreational drug use in patients presenting to an urban emergency department in Switzerland.

Liakoni E; Dolder PC; Rentsch K; Liechti ME. Swiss medical weekly. 2015.

Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans.

Steuer AE; Schmidhauser C; Schmid Y; Rickli A; Liechti ME; Kraemer T. DRUG METABOLISM AND DISPOSITION. 2015.

Development and validation of an LC-MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy-methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma.

Steuer AE; Schmidhauser C; Liechti ME; Kraemer T. Drug testing and analysis. 2015.

Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships.

Schmid Y; Hysek CM; Preller KH; Bosch OG; Bilderbeck AC; Rogers RD; Quednow BB; Liechti ME. European Neuropsychopharmacology. 2015.

Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects.

Schmid Y; Rickli A; Schaffner A; Duthaler U; Grouzmann E; Hysek CM; Liechti ME. Journal of Pharmacology and Experimental Therapeutics. 2015.

Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones

Rickli A.; Hoener M.C.; Liechti M.E.. European Neuropsychopharmacology. 2015.

Monoamine transporter and receptor interaction profiles of psychoactive benzofurans

Rickli, Anna; Kopf, Simone; Hoener, Marius C.; Liechti, Matthias E.. Clinical toxicology (Philadelphia, Pa.). 2015.

Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.

Liechti M. Schweizerische Medizinische Wochenschrift. 2015.

Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.

Liechti M. Schweizerische Medizinische Wochenschrift. 2015.

Pharmacological characterization of designer cathinones in vitro

Liechti, M.. TOXICOLOGY LETTERS. 2015.

Pharmacological profile of novel psychoactive benzofurans.

Rickli A; Kopf S; Hoener MC; Liechti ME. British Journal of Pharmacology. 2015.

Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)

Rickli A.; Luethi D.; Reinisch J.; Buchy D.; Hoener M.C.; Liechti M.E.. NEUROPHARMACOLOGY. 2015.

Stress-Induced In Vivo Recruitment of Human Cytotoxic Natural Killer Cells Favors Subsets with Distinct Receptor Profiles and Associates with Increased Epinephrine Levels.

Bigler MB; Egli SB; Hysek CM; Hoenger G; Schmied L; Baldin FS; Marquardsen FA; Recher M; Liechti ME; Hess C; Berger CT. PLoS One. 2015.

Swiss university students' attitudes toward pharmacological cognitive enhancement

Maier L.J.; Liakoni E.; Schildmann J.; Schaub M.P.; Liechti M.E.. PLoS One. 2015.

The Use of Prescription Drugs, Recreational Drugs, and "Soft Enhancers" for Cognitive Enhancement among Swiss Secondary School Students

Liakoni, Evangelia; Schaub, Michael P.; Maier, Larissa J.; Glauser, Gaelle-Vanessa; Liechti, Matthias E.. PLoS One. 2015.

Acute cocaine-related health problems in patients presenting to an urban emergency department in Switzerland: a case series.

Bodmer M; Enzler F; Liakoni E; Bruggisser M; Liechti ME. BMC research notes. 2014.

Acute cocaine-related health problems in patients presenting to an urban emergency department in Switzerland: a case series.

Bodmer M; Enzler F; Liakoni E; Bruggisser M; Liechti ME. BMC research notes. 2014.

Acute effects of 3,4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects.

Seibert J; Hysek CM; Penno CA; Schmid Y; Kratschmar DV; Liechti ME; Odermatt A. NEUROENDOCRINOLOGY. 2014.

Acute effects of methylphenidate in healthy subjects alone or in combination with MDMA

Schmid, Yasmin; Hysek, Cedric M.; Liechti, Mattthias E.. Clinical toxicology (Philadelphia, Pa.). 2014.

Analytical interference of 4-hydroxy-3-methoxymethamphetamine with the measurement of plasma free normetanephrine by ultra-high pressure liquid chromatography-tandem mass spectrometry

Dunand M.; Donzelli M.; Rickli A.; Hysek C.M.; Liechti M.E.; Grouzmann E.. Clinical biochemistry. 2014.

Differential effects of MDMA and methylphenidate on social cognition.

Schmid Y; Hysek CM; Simmler LD; Crockett MJ; Quednow BB; Liechti ME. Journal of psychopharmacology (Oxford, England). 2014.

Effects of MDMA on body temperature in humans.

Liechti ME. Temperature (Austin, Tex.). 2014.

Effects of MDMA on body temperature in humans.

Liechti ME. Temperature (Austin, Tex.). 2014.

Effects of methylphenidate and MDMA (ecstasy) on appraisal of erotic stimuli

Schmid, Y.; Quednow, B. B.; Liechti, M. E.. European Neuropsychopharmacology. 2014.

In vitro pharmacology of pipradrol derivatives, 3,4-methylenedioxypyrovalerone, and naphyrone

Liechti, Matthias; Simmler, Linda; Rickli, Anna; Hoener, Marius. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2014.

MDMA effects consistent across laboratories.

Kirkpatrick MG; Baggott MJ; Mendelson JE; Galloway GP; Liechti ME; Hysek CM; de Wit H. Psychopharmacology. 2014.

MDMA enhances emotional empathy and prosocial behavior.

Hysek CM; Schmid Y; Simmler LD; Domes G; Heinrichs M; Eisenegger C; Preller KH; Quednow BB; Liechti ME. Social Cognitive and Affective Neuroscience. 2014.

Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.

Simmler LD; Rickli A; Hoener MC; Liechti ME. NEUROPHARMACOLOGY. 2014.

Monoamine transporter and receptor interaction profiles of halogenated phenethylamines

Rickli, Anna; Hoener, Marius C.; Liechti, Matthias E.. Clinical toxicology (Philadelphia, Pa.). 2014.

Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.

Hysek CM; Simmler LD; Schillinger N; Meyer N; Schmid Y; Donzelli M; Grouzmann E; Liechti ME. International Journal of Neuropsychopharmacology. 2014.

Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives

Simmler L.D.; Rickli A.; Schramm Y.; Hoener M.C.; Liechti M.E.. Biochemical pharmacology. 2014.

The pharmacology of novel psychoactive substances

Liechti, Matthias E.; Simmler, Linda D.; Rickli, Anna; Hoener, Marius C.. Clinical toxicology (Philadelphia, Pa.). 2014.

Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence.

Simmler LD; Wandeler R; Liechti ME. BMC research notes. 2013.

Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans: Lost in translation

Hysek C.M.; Schmid Y.; Rickli A.; Liechti M.E.. British Journal of Pharmacology. 2013.

Effects of MDMA and methylphenidate on steroid levels in healthy humans

Seibert, Julia; Hysek, Cedric M.; Liechti, Matthias E.; Odermatt, Alex. TOXICOLOGY LETTERS. 2013.

Pharmacological characterization of designer cathinones in vitro.

Simmler LD; Buser TA; Donzelli M; Schramm Y; Dieu LH; Huwyler J; Chaboz S; Hoener MC; Liechti ME. British Journal of Pharmacology. 2013.

Symptoms, toxicities, and analytical results for a patient after smoking herbs containing the novel synthetic cannabinoid MAM-2201

Derungs A.; Schwaninger A.E.; Mansella G.; Bingisser R.; Kraemer T.; Liechti M.E.. Forensic Toxicology. 2013.

To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students.

Maier LJ; Liechti ME; Herzig F; Schaub MP. PLoS One. 2013.

α₁-Adrenergic receptors contribute to the acute effects of 3,4-methylenedioxymethamphetamine in humans.

Hysek CM; Fink AE; Simmler LD; Donzelli M; Grouzmann E; Liechti ME. Journal of clinical psychopharmacology. 2013.

[Methylphenidate misuse].

Bruggisser M; Bodmer M; Liechti ME. Praxis. 2012.

Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.

Hysek C; Schmid Y; Rickli A; Simmler LD; Donzelli M; Grouzmann E; Liechti ME. British Journal of Pharmacology. 2012.

Demographics, Co-Use of Illicit Drugs, and Clinical Presentation of Patients with Acute Cocaine Intoxication Presenting to a Swiss Emergency Department

Bodmer, M.; Bruggisser, M.; Enzler, F.; Liechti, M.. Clinical toxicology (Philadelphia, Pa.). 2012.

Duloxetine Inhibits Effects of MDMA ("Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study

Hysek, Cedric M.; Simmler, Linda D.; Nicola, Valentina G.; Vischer, Nerina; Donzelli, Massimiliano; Kraehenbuehl, Stephan; Grouzmann, Eric; Huwyler, Joerg; Hoener, Marius C.; Liechti, Matthias E.. PLoS One. 2012.

Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex.

Hysek CM; Liechti ME. Psychopharmacology. 2012.

Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers.

Hysek,Cédric M; Brugger,Robin; Simmler,Linda D; Bruggisser,Marcel; Donzelli,Massimiliano; Grouzmann,Eric; Hoener,Marius C; Liechti,Matthias E. Journal of Pharmacology and Experimental Therapeutics. 2012.

Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.

Hysek CM; Brugger R; Simmler LD; Bruggisser M; Donzelli M; Grouzmann E; Hoener MC; Liechti ME. Journal of Pharmacology and Experimental Therapeutics. 2012.

MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions.

Hysek CM; Domes G; Liechti ME. Psychopharmacology. 2012.

Effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) on prosocial feelings and oxytocin plasma levels in humans

Hysek, C. M.; Simmler, L. D.; Nicola, V. G.; Liechti, M. E.. European Neuropsychopharmacology. 2011.

Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets.

Bruggisser M; Bodmer M; Liechti ME. Swiss medical weekly. 2011.

Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets.

Bruggisser M; Bodmer M; Liechti ME. Swiss medical weekly. 2011.

Sex-differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects

Hysek, C. M.; Simmler, L. D.; Liechti, M. E.. European Neuropsychopharmacology. 2011.

Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.

Simmler LD; Hysek CM; Liechti ME. The Journal of clinical endocrinology and metabolism. 2011.

Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)

Derungs, Adrian; Schietzel, Simeon; Meyer, Markus R.; Maurer, Hans H.; Kraehenbuehl, Stephan; Liechti, Matthias E.. Clinical toxicology (Philadelphia, Pa.). 2011.

The Metabotropic Glutamate 2/3 Receptor Agonist LY379268 Blocked Nicotine-Induced Increases in Nucleus Accumbens Shell Dopamine only in the Presence of a Nicotine-Associated Context in Rats

D'Souza, Manoranjan S.; Liechti, Matthias E.; Ramirez-Nino, Ana M.; Kuczenski, Ronald; Markou, Athina. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2011.

The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.

Hysek CM; Simmler LD; Ineichen M; Grouzmann E; Hoener MC; Brenneisen R; Huwyler J; Liechti ME. Clinical pharmacology and therapeutics. 2011.

Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy).

Hysek CM; Vollenweider FX; Liechti ME. EMERGENCY MEDICINE JOURNAL. 2010.

Retrospective analysis of stimulant abuse cases reported to the Swiss Toxicological Information Centre during 1997-2009.

Bruggisser M; Ceschi A; Bodmer M; Wilks MF; Kupferschmidt H; Liechti ME. Swiss medical weekly. 2010.

Role of the norepinephrine uptake transporter in the mechanism of action of MDMA (Ecstasy)

Hysek, C. M.; Ineichen, M.; Nicola, V. G.; Simmler, L.; Liechti, M. E.. European Neuropsychopharmacology. 2010.

[Intoxication with lithium].

Fiegler K; Liechti ME; Bodmer M; Bruggisser M. Praxis. 2009.

[Renal failure and hemolytic anemia. Rifampicin associated interstitial nephropathy with immune hemolytic anemia].

Bodmer M; Haschke M; Rätz Bravo AE; Liechti ME. Praxis. 2009.

INTERACTING CARDIOVASCULAR EFFECTS OF PINDOLOL AND MDMA (ECSTASY)

Liechti, M. E.; Hysek, C.; Vollenweider, F. X.. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2009.

[Intoxication with an unknown sedative substance].

Bodmer M; Christ A; Liechti ME. Praxis. 2008.

Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies.

Liechti ME; Markou A. CNS drugs. 2008.

Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.

Liechti ME; Markou A. European journal of pharmacology. 2007.

Metabotropic glutamate 2/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats.

Liechti ME; Markou A. Biochemical pharmacology. 2007.

Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence.

Liechti ME; Lhuillier L; Kaupmann K; Markou A. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2007.

Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.

Liechti ME; Kunz I; Greminger P; Speich R; Kupferschmidt H. Drug and alcohol dependence. 2006.

Acute medical problems due to Ecstasy use. Case-series of emergency department visits.

Liechti ME; Kunz I; Kupferschmidt H. Swiss medical weekly. 2005.

Is ecstasy perceived to be safe? A critical survey.

Gamma A; Jerome L; Liechti ME; Sumnall HR. Drug and alcohol dependence. 2005.

MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task.

Vollenweider FX; Liechti ME; Paulus MP. Journal of psychopharmacology (Oxford, England). 2005.

Gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL): analysis of overdose cases reported to the Swiss Toxicological Information Centre.

Liechti ME; Kupferschmidt H. Swiss medical weekly. 2004.

["Ecstasy" (MDMA): pharmacology, toxicology, and treatment of acute intoxication].

Liechti ME. Deutsche medizinische Wochenschrift (1946). 2003.

[Coma in a 21-year-old party attendant].

Liechti ME; Mathys J. Der Internist. 2003.

[What is your diagnosis? Acute postrenal kidney failure with hyperkalemia and metabolic acidosis in urinary retention and urinary tract infection].

Liechti ME. Praxis. 2003.

Clostridium septicum aortitis in a patient with colon carcinoma.

Liechti ME; Schöb O; Kacl GM; Caduff B. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2003.

Plasmodium falciparum cerebral malaria complicated by disseminated intravascular coagulation and symmetrical peripheral gangrene: case report and review.

Liechti ME; Zumsteg V; Hatz CF; Herren T. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2003.

[Pneumomediastinum].

Liechti ME; Achermann E. Deutsche medizinische Wochenschrift (1946). 2002.

[Pneumomediastinum after tooth extraction].

Liechti ME; Nyfeler B; Achermann E; Gerber D; Norlindh TS. Praxis. 2002.

Acute psychological and neurophysiological effects of MDMA in humans.

Vollenweider FX; Liechti ME; Gamma A; Greer G; Geyer M. Journal of psychoactive drugs. 2002.

Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.

Liechti ME; Geyer MA; Hell D; Vollenweider FX. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2001.

Gender differences in the subjective effects of MDMA.

Liechti ME; Gamma A; Vollenweider FX. Psychopharmacology. 2001.

Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.

Liechti ME; Vollenweider FX. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 2001.

3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans.

Gamma A; Buck A; Berthold T; Liechti ME; Vollenweider FX. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2000.

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans.

Liechti ME; Vollenweider FX. European Neuropsychopharmacology. 2000.

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram.

Liechti ME; Baumann C; Gamma A; Vollenweider FX. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2000.

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.

Liechti ME; Saur MR; Gamma A; Hell D; Vollenweider FX. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2000.

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

Liechti ME; Vollenweider FX. Journal of psychopharmacology (Oxford, England). 2000.

Is a single dose of MDMA harmless?

Vollenweider FX; Gamma A; Liechti M; Huber T. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 1999.

Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.

Vollenweider FX; Gamma A; Liechti M; Huber T. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 1998.